NICOSAN for the Treatment of Sickle Cell Disease

In clinical trials NICOSAN eliminated crises in 80% of patients and
in the refractory 20% reduced crises by half.

This relatively new treatment for sickle cell being
produced in Nigeria by an American company called NICOSAN®,
it’s proprietary name is NIPRISAN® was developed on the
premise of traditional Nigerian plant based medicinal practices
for the treatment of sickle cell disease. Although this drug
was developed in Nigeria, the man behind it, Dr. Ramesh Pandey
is a distinguished biochemist who has worked for the
National Cancer Institute's (NCI) Frederick Cancer